Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma

Masato Taoka, Noriaki Morofuji, Yoshio Yamauchi, Hidenori Ojima, Daisuke Kubota, Goro Terukina, Yuko Nobe, Hiroshi Nakayama, Nobuhiro Takahashi, Tomoo Kosuge, Toshiaki Isobe, Tadashi Kondo

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study used global protein expression profiling to search for biomarkers to predict early recurrent hepatocellular carcinoma (HCC). HCC tissues surgically resected from patients with or without recurrence within 2 years (early recurrent) after surgery were compared with adjacent nontumor tissue and with normal liver tissue. We used the PROTOMAP strategy for comparative profiling, which integrates denaturing polyacrylamide gel electrophoresis migratory rates and high-resolution, semiquantitative mass-spectrometry-based identification of in-gel-digested tryptic peptides. PROTOMAP allows examination of global changes in the size, topography, and abundance of proteins in complex tissue samples. This approach identified 8438 unique proteins from 45-708 nonredundant peptides and generated a proteome-wide map of changes in expression and proteolytic events potentially induced by intrinsic apoptotic/necrotic pathways. In the early recurrent HCC tissue, 87 proteins were differentially expressed (≥20-fold) relative to the other tissues, 46 of which were up-regulated or specifically proteolyzed and 41 of which were down-regulated. This data set consisted of proteins that fell into various functional categories, including signal transduction and cell organization and, notably, the major catalytic pathways responsible for liver function, such as the urea cycle and detoxification metabolism. We found that aberrant proteolysis appeared to occur frequently during recurrence of HCC in several key signal transducers, including STAT1 and δ-catenin. Further investigation of these proteins will facilitate the development of novel clinical applications.

Original languageEnglish
Pages (from-to)4847-4858
Number of pages12
JournalJournal of Proteome Research
Volume13
Issue number11
DOIs
Publication statusPublished - 2014 Nov 7

Fingerprint

Biomarkers
Hepatocellular Carcinoma
Tissue
Proteins
Liver
Proteolysis
Recurrence
Catenins
Signal transduction
Detoxification
Peptides
Proteome
Electrophoresis
Transducers
Metabolism
Surgery
Topography
Mass spectrometry
Urea
Polyacrylamide Gel Electrophoresis

Keywords

  • biomarker
  • hepatocellular carcinoma
  • mass spectrometry
  • proteomics
  • PROTOMAP

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma. / Taoka, Masato; Morofuji, Noriaki; Yamauchi, Yoshio; Ojima, Hidenori; Kubota, Daisuke; Terukina, Goro; Nobe, Yuko; Nakayama, Hiroshi; Takahashi, Nobuhiro; Kosuge, Tomoo; Isobe, Toshiaki; Kondo, Tadashi.

In: Journal of Proteome Research, Vol. 13, No. 11, 07.11.2014, p. 4847-4858.

Research output: Contribution to journalArticle

Taoka, M, Morofuji, N, Yamauchi, Y, Ojima, H, Kubota, D, Terukina, G, Nobe, Y, Nakayama, H, Takahashi, N, Kosuge, T, Isobe, T & Kondo, T 2014, 'Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma', Journal of Proteome Research, vol. 13, no. 11, pp. 4847-4858. https://doi.org/10.1021/pr500262p
Taoka, Masato ; Morofuji, Noriaki ; Yamauchi, Yoshio ; Ojima, Hidenori ; Kubota, Daisuke ; Terukina, Goro ; Nobe, Yuko ; Nakayama, Hiroshi ; Takahashi, Nobuhiro ; Kosuge, Tomoo ; Isobe, Toshiaki ; Kondo, Tadashi. / Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma. In: Journal of Proteome Research. 2014 ; Vol. 13, No. 11. pp. 4847-4858.
@article{4d78196bdcda4b38884fcb9c371313a6,
title = "Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma",
abstract = "This study used global protein expression profiling to search for biomarkers to predict early recurrent hepatocellular carcinoma (HCC). HCC tissues surgically resected from patients with or without recurrence within 2 years (early recurrent) after surgery were compared with adjacent nontumor tissue and with normal liver tissue. We used the PROTOMAP strategy for comparative profiling, which integrates denaturing polyacrylamide gel electrophoresis migratory rates and high-resolution, semiquantitative mass-spectrometry-based identification of in-gel-digested tryptic peptides. PROTOMAP allows examination of global changes in the size, topography, and abundance of proteins in complex tissue samples. This approach identified 8438 unique proteins from 45-708 nonredundant peptides and generated a proteome-wide map of changes in expression and proteolytic events potentially induced by intrinsic apoptotic/necrotic pathways. In the early recurrent HCC tissue, 87 proteins were differentially expressed (≥20-fold) relative to the other tissues, 46 of which were up-regulated or specifically proteolyzed and 41 of which were down-regulated. This data set consisted of proteins that fell into various functional categories, including signal transduction and cell organization and, notably, the major catalytic pathways responsible for liver function, such as the urea cycle and detoxification metabolism. We found that aberrant proteolysis appeared to occur frequently during recurrence of HCC in several key signal transducers, including STAT1 and δ-catenin. Further investigation of these proteins will facilitate the development of novel clinical applications.",
keywords = "biomarker, hepatocellular carcinoma, mass spectrometry, proteomics, PROTOMAP",
author = "Masato Taoka and Noriaki Morofuji and Yoshio Yamauchi and Hidenori Ojima and Daisuke Kubota and Goro Terukina and Yuko Nobe and Hiroshi Nakayama and Nobuhiro Takahashi and Tomoo Kosuge and Toshiaki Isobe and Tadashi Kondo",
year = "2014",
month = "11",
day = "7",
doi = "10.1021/pr500262p",
language = "English",
volume = "13",
pages = "4847--4858",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma

AU - Taoka, Masato

AU - Morofuji, Noriaki

AU - Yamauchi, Yoshio

AU - Ojima, Hidenori

AU - Kubota, Daisuke

AU - Terukina, Goro

AU - Nobe, Yuko

AU - Nakayama, Hiroshi

AU - Takahashi, Nobuhiro

AU - Kosuge, Tomoo

AU - Isobe, Toshiaki

AU - Kondo, Tadashi

PY - 2014/11/7

Y1 - 2014/11/7

N2 - This study used global protein expression profiling to search for biomarkers to predict early recurrent hepatocellular carcinoma (HCC). HCC tissues surgically resected from patients with or without recurrence within 2 years (early recurrent) after surgery were compared with adjacent nontumor tissue and with normal liver tissue. We used the PROTOMAP strategy for comparative profiling, which integrates denaturing polyacrylamide gel electrophoresis migratory rates and high-resolution, semiquantitative mass-spectrometry-based identification of in-gel-digested tryptic peptides. PROTOMAP allows examination of global changes in the size, topography, and abundance of proteins in complex tissue samples. This approach identified 8438 unique proteins from 45-708 nonredundant peptides and generated a proteome-wide map of changes in expression and proteolytic events potentially induced by intrinsic apoptotic/necrotic pathways. In the early recurrent HCC tissue, 87 proteins were differentially expressed (≥20-fold) relative to the other tissues, 46 of which were up-regulated or specifically proteolyzed and 41 of which were down-regulated. This data set consisted of proteins that fell into various functional categories, including signal transduction and cell organization and, notably, the major catalytic pathways responsible for liver function, such as the urea cycle and detoxification metabolism. We found that aberrant proteolysis appeared to occur frequently during recurrence of HCC in several key signal transducers, including STAT1 and δ-catenin. Further investigation of these proteins will facilitate the development of novel clinical applications.

AB - This study used global protein expression profiling to search for biomarkers to predict early recurrent hepatocellular carcinoma (HCC). HCC tissues surgically resected from patients with or without recurrence within 2 years (early recurrent) after surgery were compared with adjacent nontumor tissue and with normal liver tissue. We used the PROTOMAP strategy for comparative profiling, which integrates denaturing polyacrylamide gel electrophoresis migratory rates and high-resolution, semiquantitative mass-spectrometry-based identification of in-gel-digested tryptic peptides. PROTOMAP allows examination of global changes in the size, topography, and abundance of proteins in complex tissue samples. This approach identified 8438 unique proteins from 45-708 nonredundant peptides and generated a proteome-wide map of changes in expression and proteolytic events potentially induced by intrinsic apoptotic/necrotic pathways. In the early recurrent HCC tissue, 87 proteins were differentially expressed (≥20-fold) relative to the other tissues, 46 of which were up-regulated or specifically proteolyzed and 41 of which were down-regulated. This data set consisted of proteins that fell into various functional categories, including signal transduction and cell organization and, notably, the major catalytic pathways responsible for liver function, such as the urea cycle and detoxification metabolism. We found that aberrant proteolysis appeared to occur frequently during recurrence of HCC in several key signal transducers, including STAT1 and δ-catenin. Further investigation of these proteins will facilitate the development of novel clinical applications.

KW - biomarker

KW - hepatocellular carcinoma

KW - mass spectrometry

KW - proteomics

KW - PROTOMAP

UR - http://www.scopus.com/inward/record.url?scp=84908884093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908884093&partnerID=8YFLogxK

U2 - 10.1021/pr500262p

DO - 10.1021/pr500262p

M3 - Article

C2 - 24967658

AN - SCOPUS:84908884093

VL - 13

SP - 4847

EP - 4858

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 11

ER -